Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

J. K. Overbeek; R. ter Heine; H. M.W. Verheul; E. Chatelut; M. A. Rudek; H. Gurney; R. Plummer; D. C. Gilbert; T. Buclin; D. M. Burger; H. J. Bloemendal; N. P. van Erp

doi:10.1016/j.esmoop.2022.100749

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

J. K. Overbeek, R. ter Heine, H. M.W. Verheul, E. Chatelut, M. A. Rudek, H. Gurney, R. Plummer, D. C. Gilbert, T. Buclin, D. M. Burger, H. J. Bloemendal, N. P. van Erp

Faculty of Medicine, Health and Human Sciences

Research output: Contribution to journal › Editorial › peer-review

6 Citations (Scopus)

47 Downloads (Pure)

Original language	English
Article number	100749
Pages (from-to)	1-8
Number of pages	8
Journal	ESMO Open
Volume	8
Issue number	1
Early online date	3 Jan 2023
DOIs	https://doi.org/10.1016/j.esmoop.2022.100749
Publication status	Published - Feb 2023

Bibliographical note

Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Access to Document

10.1016/j.esmoop.2022.100749Licence: CC BY-NC-ND

Publisher version (open access)Final published version, 614 KBLicence: CC BY-NC-ND

Cite this

Overbeek, J. K., Heine, R. T., Verheul, H. M. W., Chatelut, E., Rudek, M. A., Gurney, H., Plummer, R., Gilbert, D. C., Buclin, T., Burger, D. M., Bloemendal, H. J., & van Erp, N. P. (2023). Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs. ESMO Open, 8(1), 1-8. Article 100749. https://doi.org/10.1016/j.esmoop.2022.100749

@article{94d946e9239d40a695bb8aff4605d340,

title = "Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs",

author = "Overbeek, {J. K.} and Heine, {R. ter} and Verheul, {H. M.W.} and E. Chatelut and Rudek, {M. A.} and H. Gurney and R. Plummer and Gilbert, {D. C.} and T. Buclin and Burger, {D. M.} and Bloemendal, {H. J.} and {van Erp}, {N. P.}",

note = "Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2023",

month = feb,

doi = "10.1016/j.esmoop.2022.100749",

language = "English",

volume = "8",

pages = "1--8",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Off-label, but on target

T2 - the evidence needed to implement alternative dosing regimens of anticancer drugs

AU - Overbeek, J. K.

AU - Heine, R. ter

AU - Verheul, H. M.W.

AU - Chatelut, E.

AU - Rudek, M. A.

AU - Gurney, H.

AU - Plummer, R.

AU - Gilbert, D. C.

AU - Buclin, T.

AU - Burger, D. M.

AU - Bloemendal, H. J.

AU - van Erp, N. P.

N1 - Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2023/2

Y1 - 2023/2

UR - http://www.scopus.com/inward/record.url?scp=85146039991&partnerID=8YFLogxK

U2 - 10.1016/j.esmoop.2022.100749

DO - 10.1016/j.esmoop.2022.100749

M3 - Editorial

C2 - 36603522

AN - SCOPUS:85146039991

SN - 2059-7029

VL - 8

SP - 1

EP - 8

JO - ESMO Open

JF - ESMO Open

IS - 1

M1 - 100749

ER -

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

Bibliographical note

Access to Document

Other files and links

Cite this